Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.60    0.00 (0.00%)
Bid:
10.20
Ask:
11.00
Spread: 0.80 (7.843%)
Market Cap: £14.73m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Director/PDMR Shareholding

5 Dec 2019 07:00

RNS Number : 7243V
Ebiquity PLC
05 December 2019
 

Ebiquity Plc

("Ebiquity" or "the Company")

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

Ebiquity announces that on 4 December 2019 the following share option award ("Award") over ordinary shares of 25 pence each in the share capital of the Company was made to Alan Newman (Interim Chief Executive Officer and Chief Financial Officer). This Award relates to the period which commenced on 1 January 2019 and is part of a number of awards made to the senior management team.

 

Name of PDMR

Share scheme plan

Number of Ordinary Shares subject to the Award

Alan Newman

Ebiquity 2012 Executive Share Option Plan

410,000

 

The Award will vest subject to continued employment and the satisfaction of the certain performance criteria. 75% of the shares subject to the Award will vest dependent on earnings per share growth over the three-year period to 31 December 2021. The remaining 25% of the shares subject to the Award will vest dependent on total shareholder return of the Company compared to the total shareholder return of the AIM Media Index over the three-year period to 31 December 2021.

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

5 December 2019

 

Enquiries:

 

Ebiquity plc

Mark Sanford, Company Secretary

 

Numis

Nick Westlake

Hugo Rubenstein

020 7650 9600

 

 

020 7260 1000

 

 

Dealing Notification Form

 

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Alan Newman

 

2

Reason for the notification

 

a)

Position/status:

Interim Chief Executive Officer and Chief Financial Officer

 

b)

Initial notification/Amendment:

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name:

Ebiquity plc

 

b)

LEI:

2138004YRTDJ7FJSWF20

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument:

Identification code:

 

Options over ordinary shares of 25p each

 

b)

Nature of the transaction:

Grant of share option over ordinary shares of 25p each

 

c)

Price(s) and volume(s):

 

 

 

 

Price(s)

Volume(s)

nil

410,000

d)

Aggregated information:

·; Aggregated volume:

·; Price:

 

Price(s)

Volume(s)

nil

410,000

e)

Date of the transaction:

4 December 2019

 

f)

Place of the transaction:

 N/A

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUGGAPPUPBGMC
Date   Source Headline
4th Jun 20192:25 pmRNSAGM resolutions passed
30th May 20193:20 pmRNSHolding(s) in Company
1st May 20197:00 amRNSTotal Voting Rights
30th Apr 201912:30 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSAnnual Report
18th Apr 20193:05 pmRNSIssue of Shares
12th Apr 201910:45 amRNSCorrection - Issue of Shares
9th Apr 20197:00 amRNSIssue of Shares
2nd Apr 201910:55 amRNSDirector/PDMR Shareholding
1st Apr 20194:40 pmRNSIssue of Shares
27th Mar 201912:25 pmRNSDirector/PDMR Shareholding
25th Mar 20192:30 pmRNSCorrection - Dividend payment schedule
25th Mar 20197:00 amRNSUnaudited Preliminary Results
1st Mar 20192:15 pmRNSTotal Voting Rights
22nd Feb 20193:55 pmRNSIssue of Shares
18th Feb 20197:00 amRNSHolding(s) in Company
12th Feb 20197:00 amRNSPre-close Trading Update
1st Feb 20197:00 amRNSTotal Voting Rights
23rd Jan 20194:50 pmRNSReplacement: Issue of Shares
23rd Jan 20193:25 pmRNSIssue of Shares
14th Jan 20193:35 pmRNSIssue of Shares
3rd Jan 20192:55 pmRNSIssue of Shares
2nd Jan 201911:40 amRNSCompletion of the disposal of the AdIntel division
2nd Jan 201911:40 amRNSDirectorate Change
2nd Jan 20197:00 amRNSTotal Voting Rights
14th Dec 20187:00 amRNSDirectorate Change
5th Dec 20181:45 pmRNSIssue of Shares
22nd Nov 20187:00 amRNSStatement re CMA final clearance notification
22nd Nov 20187:00 amRNSTrading Update
1st Nov 20187:00 amRNSTotal Voting Rights
24th Oct 20182:40 pmRNSIssue of Shares
23rd Oct 20182:05 pmRNSHolding(s) in Company
18th Oct 20184:06 pmRNSIssue of Shares
15th Oct 20187:00 amRNSIssue of Shares
11th Oct 20187:10 amRNSStatement re CMA Provisional Findings
10th Oct 201812:15 pmRNSDirectorate Change
4th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSTotal Voting Rights
27th Sep 20189:10 amRNSIssue of Shares
25th Sep 20187:00 amRNSDirectorate Change
25th Sep 20187:00 amRNSInterim Results
3rd Aug 20188:51 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
27th Jul 20188:59 amRNSHolding(s) in Company
27th Jul 20188:55 amRNSHolding(s) in Company
27th Jul 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jul 20187:00 amRNSInterim Trading Update
20th Jul 20185:00 pmRNSHolding(s) in Company
11th Jul 20183:05 pmRNSAward of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.